findmyKOL
Clinical trialNCT04320342CompletedPhase 3Interventional

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

SponsorChiesi Farmaceutici S.p.A.Enrollment3,433COPDCOPD Exacerbation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

436 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Chiesi Clinical Trial Site 032107

    Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032112

    Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032113

    Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032115

    Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032121

    Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032108

    La Plata, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032114

    Mar del Plata, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032118

    Mar del Plata, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032102

    Monte Grande, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032106

    Quilmes, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032116

    San Fernando, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032110

    San Juan Bautista, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032100

    Vicente López, Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032111

    Córdoba, Córdoba Province, Argentina

  • Chiesi Clinical Trial Site 032120

    Concepción del Uruguay, Entre Ríos Province, Argentina

  • Chiesi Clinical Trial Site 032101

    Rosario, Santa Fe Province, Argentina

  • Chiesi Clinical Trial Site 032132

    Rosario, Santa Fe Province, Argentina

  • Chiesi Clinical Trial Site 032117

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Chiesi Clinical Trial Site 032125

    Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032130

    Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032133

    Buenos Aires, Argentina

  • Chiesi Clinical Trial Site 032103

    Ciudad Autonoma de Buenos Aire, Argentina

  • Chiesi Clinical Trial Site 032109

    Ciudad Autonoma de Buenos Aire, Argentina

  • Chiesi Clinical Trial Site 032122

    Córdoba, Argentina

  • Chiesi Clinical Trial Site 032131

    Lobos, Argentina

  • Chiesi Clinical Trial Site 032119

    Mar del Plata, Argentina

  • Chiesi Clinical Trial Site 032105

    Mendoza, Argentina

  • Chiesi Clinical Trial Site 032126

    Mendoza, Argentina

  • Chiesi Clinical Trial Site 032129

    Mendoza, Argentina

  • Chiesi Clinical Trial Site 032123

    Paraná, Argentina

  • Chiesi Clinical Trial Site 032128

    Rosario, Argentina

  • Chiesi Clinical Trial Site 032134

    San Miguel de Tucumán, Argentina

  • Chiesi Clinical Trial Site 032136

    San Miguel de Tucumán, Argentina

  • Chiesi Clinical Trial Site 032127

    San Rafael, Argentina

  • Chiesi Clinical Trial Site 032124

    Santa Fe, Argentina

Bulgaria
  • Chiesi Clinical Trial Site 100125

    Gabrovo, Bulgaria

  • Chiesi Clinical Trial Site 100109

    Haskovo, Bulgaria

  • Chiesi Clinical Trial Site 100129

    Kozloduy, Bulgaria

  • Chiesi Clinical Trial Site 100111

    Lovech, Bulgaria

  • Chiesi Clinical Trial Site 100115

    Montana, Bulgaria

396 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Apr 2022
Primary completion
12 Jan 2026
Completion
12 Jan 2026
Last update posted
30 Jan 2026
Registered enrollment
3,433
Registry id
NCT04320342

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-002389-16

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.